Perrigo | PRGO - Активы





Активы Изменить Дата
AbbVie USD 133.96B 62M 2025-12
Abbott USD 110.43B 23.72B 2026-03
Bayer EUR 104.54B 331M 2025-12
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Coherus Biosciences USD 258.34M 258.18M 2025-12
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Dr.Reddys Laboratories INR 562.9B 20.89B 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
J&J USD 200.89B 1.68B 2026-03
Merck USD 136.87B 7.32B 2025-12
Nestle CHF 127.15B 2.97B 2025-12
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 8.54B 1.55B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Phibro Animal Health USD 1.41B 20.03M 2025-12
Prestige Brands USD 3.49B 52.46M 2025-12
Reckitt Benckiser GBP 25.3B 1.11B 2024-12
Sanofi EUR 128.02B 1.22B 2026-03
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
Teva Pharmaceutical Industries USD 40.04B 708M 2026-03
Xeris Pharmaceuticals USD 383.53M 13.34M 2025-12
Zoetis USD 15.47B 308M 2025-12